Skip to main content

Caspofungin: first approved agent in a new class of antifungals

Publication ,  Journal Article
Johnson, MD; Perfect, JR
Published in: Expert Opinion on Pharmacotherapy
2003

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Expert Opinion on Pharmacotherapy

DOI

ISSN

1465-6566

Publication Date

2003

Volume

4

Issue

5

Start / End Page

807 / 823

Publisher

Informa UK Limited

Related Subject Headings

  • Pharmacology & Pharmacy
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Johnson, M. D., & Perfect, J. R. (2003). Caspofungin: first approved agent in a new class of antifungals. Expert Opinion on Pharmacotherapy, 4(5), 807–823. https://doi.org/10.1517/eoph.4.5.807.22216
Johnson, Melissa D., and John R. Perfect. “Caspofungin: first approved agent in a new class of antifungals.” Expert Opinion on Pharmacotherapy 4, no. 5 (2003): 807–23. https://doi.org/10.1517/eoph.4.5.807.22216.
Johnson MD, Perfect JR. Caspofungin: first approved agent in a new class of antifungals. Expert Opinion on Pharmacotherapy. 2003;4(5):807–23.
Johnson, Melissa D., and John R. Perfect. “Caspofungin: first approved agent in a new class of antifungals.” Expert Opinion on Pharmacotherapy, vol. 4, no. 5, Informa UK Limited, 2003, pp. 807–23. Crossref, doi:10.1517/eoph.4.5.807.22216.
Johnson MD, Perfect JR. Caspofungin: first approved agent in a new class of antifungals. Expert Opinion on Pharmacotherapy. Informa UK Limited; 2003;4(5):807–823.

Published In

Expert Opinion on Pharmacotherapy

DOI

ISSN

1465-6566

Publication Date

2003

Volume

4

Issue

5

Start / End Page

807 / 823

Publisher

Informa UK Limited

Related Subject Headings

  • Pharmacology & Pharmacy
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences